Gregory L. Verdine is Director at Wave Life Sciences Ltd. (WVE). They have made 4 open-market trades across 2 companies since 2013, most recently 2025-12-08.
CIK 0001572315
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $47K since 2013, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| WVE | SELL · 10b5-1 | 2025-12-08 | 2025-12-10 | $13.33 | $427K | -9.3% | -30.2% | -30.6% |
| WVE | SELL · 10b5-1 | 2025-08-22 | 2025-08-26 | $10.00 | $100K | -23.2% | -32.5% | -24.4% |
| WVE | SELL · 10b5-1 | 2025-06-13 | 2025-06-13 | $6.95 | $209K | +0.6% | +12.2% | +2.4% |
| WVE | SELL | 2019-11-20 | 2019-11-22 | $30.58 | $1.7M | +5.6% | -48.9% | -68.4% |
| WVE | SELL | 2018-11-14 | 2018-11-16 | $38.75 | $996K | +15.3% | +16.2% | -8.8% |
| WVE | SELL | 2016-06-15 | 2016-06-17 | $16.70 | $868K | +2.7% | +33.6% | +27.8% |
| ENTA | BUY | 2013-03-26 | 2013-03-28 | $14.00 | $47K | -17.8% | +5.4% | +5.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.